Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Hub
News
Changes
Search
Log in
Get Started
EMBLAVEO (AVIBACTAM SODIUM; AZTREONAM) | LOERadar
Viewing data from:
Latest
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
EMBLAVEO
NDA
Get alerts
AVIBACTAM SODIUM; AZTREONAM | N217906 | ABBVIE INC
1 strength
7 unique patents
2 unique exclusivities
Patents
SEC Intel
Revenue
PTAB
Reexams
Litigation
Petitions
Trials
Approvals
Label
Products
Patent Timeline
7 unique patents, 2 exclusivities by expiration date
Expired (1)
Expiring < 1yr (1)
Active (5)
Today
Exclusivity
2026
2027
2028
2029
2030
2031
2032
2033
Today
7112592
Jan. 7, 2026
7612087
Nov. 12, 2026
8471025
Aug. 12, 2031
8835455
Oct. 8, 2030
8969566
Jun. 15, 2032
9284314
Jun. 15, 2032
9695122
Jun. 15, 2032
NP
Feb. 7, 2028
GAIN
Feb. 7, 2033
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — EQ 0.5GM BASE/VIAL;1.5GM/VIAL
RLD
7 patents
2 exclusivities
▴
POWDER;INTRAVENOUS | Approved: Feb 7, 2025
Patents (7)
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
7112592
Jan 7, 2026
—
Yes
Yes
U-4147
TREATMENT OF COMPLICATED INTRA-ABDOMINAL BACTERIAL INFECTIONS IN ADULT PATIENTS
—
7612087
Nov 12, 2026
—
—
Yes
—
—
8471025
Aug 12, 2031
—
Yes
—
—
—
8835455
Oct 8, 2030
—
—
Yes
—
—
8969566
Jun 15, 2032
—
Yes
—
—
—
9284314
Jun 15, 2032
—
Yes
—
—
—
9695122
Jun 15, 2032
—
Yes
Yes
—
—
Exclusivities (2)
Code
Date
Status
GAIN
Feb 7, 2033
Active
NP
Feb 7, 2028
Active